The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model
Open accessAbstract
BACKGROUND: The human gut houses one of the most complex and abundant ecosystems composed of up to 10(13)-10(14) microorganisms. The importance of this intestinal microbiota is highlighted when a disruption of the intestinal ecosystem equilibrium appears (a phenomenon called dysbiosis) leading to an illness status, such as inflammatory bowel diseases (IBD). Indeed, the reduction of the commensal bacterium Faecalibacterium prausnitzii (one of the most prevalent intestinal bacterial species in healthy adults) has been correlated with several diseases, including IBD, and most importantly, it has been shown that this bacterium has anti-inflammatory and protective effects in pre-clinical models of colitis. Some dysbiosis disorders are characterized by functional and physiological alterations. Here, we report the beneficial effects of F. prausnitzii in the physiological changes induced by a chronic low-grade inflammation in a murine model. Chronic low-grade inflammation and gut dysfunction were induced in mice by two episodes of dinitro-benzene sulfonic acid (DNBS) instillations. Markers of inflammation, gut permeability, colonic serotonin and cytokine levels were studied. The effects of F. prausnitzii strain A2-165 and its culture supernatant (SN) were then investigated. RESULTS: No significant differences were observed in classical inflammation markers confirming that inflammation was subclinical. However, gut permeability, colonic serotonin levels and the colonic levels of the cytokines IL-6, INF-γ, IL-4 and IL-22 were higher in DNBS-treated than in untreated mice. Importantly, mice treated with either F. prausnitzii or its SN exhibited significant decreases in intestinal permeability, tissue cytokines and serotonin levels. CONCLUSIONS: Our results show that F. prausnitzii and its SN had beneficial effects on intestinal epithelial barrier impairment in a chronic low-grade inflammation model. These observations confirm the potential of this bacterium as a novel probiotic treatment in the management of gut dysfunction and low-grade inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Comparison of inflammation measures in severe and moderate colitis models [ 25 ] with the micro-inflammation model employed in this study. Severity of the colitis was assessed from differences in body weight (A), macroscopic score (B), histological score (C) and MPO activity (D) between the control non-inflamed (EtOH-PBS), control inflamed severe colitis model (DNBS-PBS (S-I)) [25], moderate colitis model (DNBS-PBS (M-I)) [25] and micro-inflammation model (DNBS-PBS (Mi-I)). Experiments were performed at least in duplicate. Comparisons involved the non-parametric Kruskal-Wallis test was used followed by a Dunn’s Multiple Comparison test. *p < 0.05 vs. DNBS-PBS, +p < 0.05 (n = 16 mice per group).](https://figures.cochat.ai/paper-figures/02da6fb8ea4a42c5a27d0526897ddb4c/faecalibacterium-prausnitzii-prevents-physiological-damages-in-a-chronic-low-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“F. prausnitzii can also reduce intestinal inflammation by affecting paracellular permeability and enhancing intestinal epithelium barrier function.270,271”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [271]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413
Self-citationThe NIH Human Microbiome Project
The NIH HMP Working Group, Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J. A., Bonazzi, V., McEwen, J. E., Wetterstrand, K. A., et al. (2009) · Genome Research · doi:10.1101/gr.096651.109 · Cited by 2,066
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Regulation of intestinal epithelial permeability by tight junctions
Suzuki, T. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1070-x · Cited by 1,343
Faecalibacterium prausnitzii and human intestinal health
Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L., Chatel, J., Sokol, H., Thomas, M., Wells, J., & Langella, P. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.003 · Cited by 1,228
Self-citationRajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041
Towards the human intestinal microbiota phylogenetic core
Tap, J., Mondot, S., Levenez, F., Pelletier, E., Caron, C., Furet, J., Ugarte, E., Muñoz‐Tamayo, R., Paslier, D. L. E., Nalin, R., et al. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.01982.x · Cited by 927 · cited 2×
“microbiota, with Actinobacteria being the third, comprising of only 3% [2].”
BackgroundWrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Chevalier-Curt, M. J., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., et al. (2013) · BMC Biology · doi:10.1186/1741-7007-11-61 · Cited by 804
Self-citationCytokine regulation of tight junctions
Capaldo, C. T., & Nusrat, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.027 · Cited by 718
Research works printed but not linked: 1
- Miquel S, Martin R, Rossi O, Bermudez-Humaran L, Chatel J, Sokol H, et al. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 2014;16(3):255–61. · DOI · Paper page
Cited by
Rivière, A., Selak, M., Lantin, D., Leroy, F., & De Vuyst, L. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00979 · Cited by 1,726
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J., & Martinez-Medina, M. (2017) · The ISME Journal · doi:10.1038/ismej.2016.176 · Cited by 874
Singh, V., Lee, G., Son, H., Koh, H., Kim, E. S., Unno, T., & Shin, J.-H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1103836 · Cited by 705
Hiippala, K., Jouhten, H., Ronkainen, A., Hartikainen, A., Kainulainen, V., Jalanka, J., & Satokari, R. (2018) · Nutrients · doi:10.3390/nu10080988 · Cited by 594
Metadata
- Authors
- Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., Sokol, H., Theodorou, V., Bercik, P., Verdu, E. F., Langella, P., & Bermúdez-Humarán, L. G.
- Affiliations
- AgroParisTech (FR)
- McMaster University (CA)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Langella, Philippe
- ORCID
- Venue
- BMC Microbiology
- Published
- 2015-03-21
- Volume
- 15
- Issue
- 1
- Pages
- 67-67
- ISSN
- 1471-2180 (ISSN-L)
- PMC
- PMC4391109
- OpenAlex
- W2043019177
- Cited by
- 309
- References
- 61
- Citations by year
- 2026: 18 · 2025: 38 · 2024: 32 · 2023: 45 · 2022: 29 · 2021: 35 · 2020: 26 · 2019: 17 · 2018: 24 · 2017: 24 · 2016: 14 · 2015: 5
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- BMC Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Crohn's and Colitis Foundation of Canada
- European Regional Development Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- Faecalibacterium prausnitzii, low-grade inflammation, gut dysbiosis, intestinal permeability, intestinal epithelial barrier, cytokines, DNBS-induced colitis, probiotics, culture supernatant, inflammatory bowel disease, gut microbiota
- MeSH terms
- Eubacteriales, Animals, Benzenesulfonates, Colon, Disease Models, Animal, Enteritis, Permeability, Serotonin, Cytokines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. https://app.cochat.ai/papers/10.1186/s12866-015-0400-1
- The paper
- Martín, R., Miquel, S., Chain, F., Natividad, J. M., Jury, J., Lu, J., Sokol, H., Theodorou, V., Bercik, P., Verdu, E. F., Langella, P., & Bermúdez-Humarán, L. G. (2015). Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. BMC Microbiology. https://doi.org/10.1186/s12866-015-0400-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.